PCT
MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application
Ryan Allway December 15th, 2021 Psychedelics VANCOUVER, BC, Dec. 15, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND” or the “Company“) (CSE: MYND) (OTC: MYNDF) is pleased to announce it has completed the National Phase filing of its Patent Cooperation Treaty (PCT) patent application, following on previously submitted provisional patent applications that describe:... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )